Stem cell banks: Investing in the promise of cancer stem cell science

Madeline Page, Rosario Isasi

Research output: Contribution to journalReview articlepeer-review


The national and international demand for stem cell lines of varying origins (eg human embryonic, induced pluripotent, somatic) and grades (eg research, clinical) is growing. This is in response to the expectation that stem cell science will radically improve our ability to understand and treat disease, to develop model systems of drug development, and to generate novel clinical therapies. A sustainable supply of stem cell lines that are scientifically and ethically sourced is both a practical and legal prerequisite for the continued progression of stem cell research towards clinical therapies. To this end, stem cell banks have become an invaluable resource, providing access to ethically sourced stem cell lines that meet high quality and safety standards.

Original languageEnglish (US)
Pages (from-to)35-39
Number of pages5
JournalDrug Discovery World
Issue number2
StatePublished - Mar 2012
Externally publishedYes

ASJC Scopus subject areas

  • Drug Discovery


Dive into the research topics of 'Stem cell banks: Investing in the promise of cancer stem cell science'. Together they form a unique fingerprint.

Cite this